Amedisys Inc

280.17+3.33+1.20%Vol 51.31K1Y Perf 42.07%
Apr 13th, 2021 14:40 DELAYED
BID279.85 ASK280.36
Open279.65 Previous Close276.84
Pre-Market- After-Market-
 - -%  - -
Target Price
301.25 
Analyst Rating
Moderate Buy 1.75
Potential %
7.64 
Finscreener Ranking
★★+     47.78
Insiders Trans % 3/6/12 mo.
-85/-92/-93 
Value Ranking
★+     44.44
Insiders Value % 3/6/12 mo.
-53/-73/-86 
Growth Ranking
★★★★+     66.31
Insiders Shares Cnt. % 3/6/12 mo.
-49/-71/-85 
Income Ranking
 —    -
Market Cap9.20B 
Earnings Rating
Sell
Price Range Ratio 52W %
71.85 
Earnings Date
5th May 2021

Today's Price Range

275.90282.16

52W Range

165.42325.12

5 Year PE Ratio Range

-283.30162.00

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
2.43%
1 Month
3.96%
3 Months
-4.43%
6 Months
9.77%
1 Year
42.07%
3 Years
325.38%
5 Years
480.38%
10 Years
723.44%

TickerPriceChg.Chg.%
AMED280.173.33001.20
AAPL134.503.26002.48
GOOG2 265.7510.96000.49
MSFT258.062.15000.84
XOM55.650.15000.27
WFC39.81-0.9600-2.35
JNJ159.10-2.5400-1.57
FB312.030.49000.16
GE13.49-0.1000-0.74
JPM154.54-1.4100-0.90
Financial StrengthValueIndustryS&P 500US Markets
0.80
0.80
0.25
0.38
20.10
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
42.80
10.70
14.00
7.80
9.80
RevenueValueIndustryS&P 500US Markets
1.58B
48.09
10.61
9.66
Earnings HistoryEstimateReportedSurprise %
Q04 20201.451.492.76
Q03 20201.272.2476.38
Q02 20200.791.3469.62
Q01 20200.971.058.25
Q04 20190.930.941.08
Q03 20190.901.1527.78
Q02 20190.971.2124.74
Q01 20190.891.1124.72
Earnings Per EndEstimateRevision %Trend
3/2021 QR1.43-1.38Negative
6/2021 QR1.49-3.87Negative
12/2021 FY6.351.93Positive
12/2022 FY7.295.65Positive
Next Report Date5th May 2021
Estimated EPS Next Report1.43
Estimates Count7
EPS Growth Next 5 Years %14.80
Volume Overview
Volume51.31K
Shares Outstanding32.85M
Trades Count1.87K
Dollar Volume78.94M
Avg. Volume200.56K
Avg. Weekly Volume167.63K
Avg. Monthly Volume230.85K
Avg. Quarterly Volume205.64K

Amedisys Inc (NASDAQ: AMED) stock closed at 276.84 per share at the end of the most recent trading day (a -2.21% change compared to the prior day closing price) with a volume of 149.30K shares and market capitalization of 9.20B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 21000 people. Amedisys Inc CEO is Paul B. Kusserow.

The one-year performance of Amedisys Inc stock is 42.07%, while year-to-date (YTD) performance is -5.62%. AMED stock has a five-year performance of 480.38%. Its 52-week range is between 165.42 and 325.12, which gives AMED stock a 52-week price range ratio of 71.85%

Amedisys Inc currently has a PE ratio of 49.60, a price-to-book (PB) ratio of 11.10, a price-to-sale (PS) ratio of 5.76, a price to cashflow ratio of 31.50, a PEG ratio of 2.32, a ROA of 12.48%, a ROC of 16.90% and a ROE of 24.38%. The company’s profit margin is 9.80%, its EBITDA margin is 14.00%, and its revenue ttm is $1.58 Billion , which makes it $48.09 revenue per share.

Of the last four earnings reports from Amedisys Inc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.43 for the next earnings report. Amedisys Inc’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for Amedisys Inc is Moderate Buy (1.75), with a target price of $301.25, which is +7.64% compared to the current price. The earnings rating for Amedisys Inc stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Amedisys Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Amedisys Inc has a Buy technical analysis rating based on Technical Indicators (ADX : 20.06, ATR14 : 12.51, CCI20 : 203.88, Chaikin Money Flow : -0.02, MACD : -10.95, Money Flow Index : 57.41, ROC : 1.00, RSI : 35.91, STOCH (14,3) : 70.02, STOCH RSI : 0.83, UO : 52.80, Williams %R : -29.98), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Amedisys Inc in the last 12-months were: Bruce D. Perkins (Buy at a value of $929 296), Christopher Gerard (Option Excercise at a value of $0), Christopher Gerard (Sold 7 300 shares of value $1 714 599 ), David Kemmerly (Option Excercise at a value of $641 002), David Kemmerly (Sold 25 646 shares of value $4 499 552 ), Denise M. Bohnert (Option Excercise at a value of $37 403), Denise M. Bohnert (Sold 1 538 shares of value $436 561 ), Michael North (Option Excercise at a value of $0), Michael North (Sold 4 069 shares of value $935 870 ), Paul B. Kusserow (Option Excercise at a value of $6 695 000), Scott G. Ginn (Option Excercise at a value of $352 815), Scott G. Ginn (Sold 12 900 shares of value $2 559 067 ), Sharon Brunecz (Option Excercise at a value of $818 900), Sharon Brunecz (Sold 10 218 shares of value $2 324 525 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (58.33 %)
7 (58.33 %)
8 (66.67 %)
Moderate Buy
1 (8.33 %)
1 (8.33 %)
1 (8.33 %)
Hold
4 (33.33 %)
4 (33.33 %)
3 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.75
Moderate Buy
1.75
Moderate Buy
1.58

Amedisys Inc

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue.

CEO: Paul B. Kusserow

Telephone: +1 225 292-2031

Address: 3854 American Way, Baton Rouge 70816, LA, US

Number of employees: 21 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

50%50%

Bearish Bullish

56%44%

News

Stocktwits